Petr Jabandziev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Petr Jabandziev has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
- Lumir Kunovsky
Department of Surgery, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic
8 shared publications Martin Jouza
Department of Pediatrics, University Hospital Brno, Brno, Czech Republic
6 shared publications- Matej Hrunka
Department of Pediatrics, University Hospital Brno, Faculty of Medicine Masaryk University Brno Czech Republic
6 shared publications - Ondrej Slaby
Central European Institute of Technology, Masaryk University, Brno, Czech Republic
6 shared publications - Zdenek Kala
Department of Surgery, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic
5 shared publications Julia Bohosova
Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
4 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
Fecal microRNA signatures as non‐invasive diagnostic and prognostic markers of pediatric inflammatory bowel diseases
Objectives: The identification of novel noninvasive diagnostic and prognostic biomarkers for pediatric inflammatory bowel disease (PIBD), including pediatric Crohn's disease (pCD) and ulcerative colitis (pUC), is crucial for improving therapeutic outcomes. Given their involvement in PIBD pathogenesis, microRNAs (miRNAs) represent promising candidates. This study investigates their potential diagnostic value and clinical utility. Methods: The study involved 81 treatment‐naive PIBD patients and 30 non‐IBD controls from whom stool samples were collected. Fecal microRNA analysis was performed using small RNA next‐generation sequencing. Differentially expressed miRNAs (DEMs) were identified in the exploratory phase (34 PIBD, 20 non‐IBD children). Logistic regression was used to establish diagnostic and prognostic miRNA expression signatures. The designed miRNA panels were validated using leave‐one‐out cross‐validation and on an independent cohort (47 PIBD, 10 non‐IBD children). Results: A diagnostic signature of four fecal miRNAs (10392‐5p, miR‐1246, miR‐4695‐5p, and miR‐5006‐5p) distinguished pCD from non‐IBD with 79.55% accuracy. Three fecal miRNAs (miR‐1290, miR‐3960, and miR‐5006‐5p) differentiated pUC from non‐IBD with 78.26% accuracy. For treatment‐naïve PIBD patients, panels of five and six miRNAs predicted residual disease activity at 3 months with 100% accuracy for pUC patients and 86.28% accuracy for pCD patients. Additionally, distinct signatures of four and six miRNAs predicted relapse within 12 months with accuracies of 96.87% (pUC) and 88.01% (pCD), respectively. Conclusion: We identified fecal miRNA expression profiles with strong diagnostic and prognostic value in PIBD. These results contribute to improved stratification of disease severity and risk, supporting the advancement of precision and personalized approaches in pediatric IBD management.
- 26 October 2026
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
Open AccessFecal microRNA signatures as non‐invasive diagnostic and prognostic markers of pediatric inflammatory bowel diseases
Objectives: The identification of novel noninvasive diagnostic and prognostic biomarkers for pediatric inflammatory bowel disease (PIBD), including pediatric Crohn's disease (pCD) and ulcerative colitis (pUC), is crucial for improving therapeutic outcomes. Given their involvement in PIBD pathogenesis, microRNAs (miRNAs) represent promising candidates. This study investigates their potential diagnostic value and clinical utility. Methods: The study involved 81 treatment‐naive PIBD patients and 30 non‐IBD controls from whom stool samples were collected. Fecal microRNA analysis was performed using small RNA next‐generation sequencing. Differentially expressed miRNAs (DEMs) were identified in the exploratory phase (34 PIBD, 20 non‐IBD children). Logistic regression was used to establish diagnostic and prognostic miRNA expression signatures. The designed miRNA panels were validated using leave‐one‐out cross‐validation and on an independent cohort (47 PIBD, 10 non‐IBD children). Results: A diagnostic signature of four fecal miRNAs (10392‐5p, miR‐1246, miR‐4695‐5p, and miR‐5006‐5p) distinguished pCD from non‐IBD with 79.55% accuracy. Three fecal miRNAs (miR‐1290, miR‐3960, and miR‐5006‐5p) differentiated pUC from non‐IBD with 78.26% accuracy. For treatment‐naïve PIBD patients, panels of five and six miRNAs predicted residual disease activity at 3 months with 100% accuracy for pUC patients and 86.28% accuracy for pCD patients. Additionally, distinct signatures of four and six miRNAs predicted relapse within 12 months with accuracies of 96.87% (pUC) and 88.01% (pCD), respectively. Conclusion: We identified fecal miRNA expression profiles with strong diagnostic and prognostic value in PIBD. These results contribute to improved stratification of disease severity and risk, supporting the advancement of precision and personalized approaches in pediatric IBD management.
- Open Access
Dietary Exposure to Purified Gliadins and Avenins: Effects on Intestinal and Immune Responses in BALB/c Mice
Dietary cereal prolamins differ in composition and gastrointestinal processing, but their shared and protein-source-specific effects on intestinal homeostasis remain incompletely defined. BALB/c mice were fed for five weeks with diets in which 70% of total protein was supplied by vital wheat gluten, purified gliadin, or purified avenin, alongside casein-fed controls. Intestinal morphology, antigen-specific plasma immunoglobulin G and A (IgG, IgA), mucosal gene expression, and small-intestinal proteomics were analysed. No overt histopathological injury or generalised inflammatory response was detected in any group. Gliadin and avenin both increased ileal villus length; avenin additionally elicited the broadest and most frequent prolamin-specific IgG response, associated with reduced intestinal interleukin-10 expression in responding animals. Proteomic profiling revealed a shared structural-metabolic signature alongside protein-specific changes in lipid handling, junctional regulation, and epithelial immune signalling. These findings indicate that wheat-and oat-derived prolamins differentially influence intestinal homeostasis and antigen recognition even at matched dietary doses, informing their evaluation as functional food ingredients. Graphical
Open AccessDietary Exposure to Purified Gliadins and Avenins: Effects on Intestinal and Immune Responses in BALB/c Mice
Dietary cereal prolamins differ in composition and gastrointestinal processing, but their shared and protein-source-specific effects on intestinal homeostasis remain incompletely defined. BALB/c mice were fed for five weeks with diets in which 70% of total protein was supplied by vital wheat gluten, purified gliadin, or purified avenin, alongside casein-fed controls. Intestinal morphology, antigen-specific plasma immunoglobulin G and A (IgG, IgA), mucosal gene expression, and small-intestinal proteomics were analysed. No overt histopathological injury or generalised inflammatory response was detected in any group. Gliadin and avenin both increased ileal villus length; avenin additionally elicited the broadest and most frequent prolamin-specific IgG response, associated with reduced intestinal interleukin-10 expression in responding animals. Proteomic profiling revealed a shared structural-metabolic signature alongside protein-specific changes in lipid handling, junctional regulation, and epithelial immune signalling. These findings indicate that wheat-and oat-derived prolamins differentially influence intestinal homeostasis and antigen recognition even at matched dietary doses, informing their evaluation as functional food ingredients. Graphical
- Open Access
- 25 September 2026
- Published by Springer Nature in BMC Pediatrics
Dysregulated microRNA expression in neonatal sepsis: validation study of potential novel biomarkers
- 25 September 2026
- Published by Springer Nature in BMC Pediatrics
Open AccessDysregulated microRNA expression in neonatal sepsis: validation study of potential novel biomarkers
- Open Access
- 15 November 2025
- Published by Springer Nature in Gut Pathogens
- Vol. 17 (1) , 90
Tissue and stool microbiome in pediatric inflammatory bowel disease patients: diversity differs in patients with relapsing and non-relapsing Crohn’s disease
Background: Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are chronic conditions characterized by periods of clinical remission and relapse. Pediatric cases (pIBD) often have a more complicated disease course, where approximately 30% will develop a relapse within a year of diagnosis. Identifying prognostic markers for pIBD is important to optimize treatment and improve long-term outcomes. Our aim was to analyze the tissue microbiome, identify microbial prognostic markers, and validate their predictive power in non-invasive fecal samples. Results: Tissue and fecal microbiome were characterized from a prospective cohort comprising 33 therapeutically naïve pCD and 23 pUC patients, and 26 non-IBD pediatric controls, using amplicon 16S rRNA gene sequencing. Disease relapse was monitored for one year. At diagnosis, relapsing pCD patients exhibited a significantly decreased alpha diversity and altered beta diversity in tissue compared to non-relapsing pCD patients. Specific taxa were differentially abundant in relapsing pCD, with Barnesiella being the most depleted genus in tissue samples. Receiver Operating Characteristic (ROC) analysis identified Barnesiella (AUC = 0.818), Butyricimonas , and Collinsella as individual microbial tissue markers discriminating pCD relapse. Combining Barnesiella with the weighted Pediatric Crohn’s Disease Activity Index (wPCDAI) further enhanced the specificity and sensitivity of the ROC analysis (AUC = 0.872 in tissue, 0.852 in feces), suggesting potential for non-invasive prognostic markers from stool. Conclusions: Tissue and fecal microbial markers can predict relapse in pCD patients with high prognostic power, providing a basis for precision medicine and personalized treatment strategies in pIBD.
- 15 November 2025
- Published by Springer Nature in Gut Pathogens
- Vol. 17 (1) , 90
Open AccessTissue and stool microbiome in pediatric inflammatory bowel disease patients: diversity differs in patients with relapsing and non-relapsing Crohn’s disease
Background: Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are chronic conditions characterized by periods of clinical remission and relapse. Pediatric cases (pIBD) often have a more complicated disease course, where approximately 30% will develop a relapse within a year of diagnosis. Identifying prognostic markers for pIBD is important to optimize treatment and improve long-term outcomes. Our aim was to analyze the tissue microbiome, identify microbial prognostic markers, and validate their predictive power in non-invasive fecal samples. Results: Tissue and fecal microbiome were characterized from a prospective cohort comprising 33 therapeutically naïve pCD and 23 pUC patients, and 26 non-IBD pediatric controls, using amplicon 16S rRNA gene sequencing. Disease relapse was monitored for one year. At diagnosis, relapsing pCD patients exhibited a significantly decreased alpha diversity and altered beta diversity in tissue compared to non-relapsing pCD patients. Specific taxa were differentially abundant in relapsing pCD, with Barnesiella being the most depleted genus in tissue samples. Receiver Operating Characteristic (ROC) analysis identified Barnesiella (AUC = 0.818), Butyricimonas , and Collinsella as individual microbial tissue markers discriminating pCD relapse. Combining Barnesiella with the weighted Pediatric Crohn’s Disease Activity Index (wPCDAI) further enhanced the specificity and sensitivity of the ROC analysis (AUC = 0.872 in tissue, 0.852 in feces), suggesting potential for non-invasive prognostic markers from stool. Conclusions: Tissue and fecal microbial markers can predict relapse in pCD patients with high prognostic power, providing a basis for precision medicine and personalized treatment strategies in pIBD.
- Open Access
- 26 August 2025
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 31 (11) , 3033-3043
Tissue MicroRNA Expression Signatures as Diagnostic Biomarkers and Predictors of Residual Disease Activity and Relapse in Treatment-Naïve Pediatric Inflammatory Bowel Disease
Background: Identifying novel diagnostic and prognostic biomarkers for pediatric inflammatory bowel diseases (PIBD), including Crohn’s disease (pCD) and ulcerative colitis (pUC), is essential for enhancing treatment outcomes. MicroRNAs (miRNAs) have been recognized for their broader relevance in PIBD pathogenesis. This study investigates their diagnostic potential and clinical utility in PIBD. Methods: This prospective, monocentric study, with retrospective validation, involved 119 PIBD patients (58 pCD, 61 pUC) and 39 non-IBD controls. Small RNA next-generation sequencing was performed on fresh-frozen gut biopsies, targeting histopathologically confirmed inflamed areas. Twenty-five dysregulated miRNA candidates were validated via RT-qPCR in formalin-fixed, paraffin-embedded gut biopsies. Logistic regression was used to establish diagnostic and prognostic miRNA expression signatures. Results: A diagnostic signature of 5 miRNAs (miR-223-3p, miR-34a-5p, miR-194-5p, miR-215-5p, miR-338-3p) distinguished pCD from non-IBD with 96.49% accuracy. Two miRNAs (miR-223-3p, miR-194-5p) differentiated pUC from non-IBD with 100% accuracy, and miR-215-5p distinguished pCD from pUC specimens with 83.54% accuracy. For treatment-naïve pCD patients, 7 miRNAs predicted residual disease activity at 3 months with 100% accuracy. Additionally, a distinct signature predicted the risk of relapse within 12 months with an accuracy of 84.21%. Conclusions: In this study, we have established tissue miRNA expression signatures with significant diagnostic and prognostic potential for use in PIBD. These findings aid in stratifying disease severity and risk, paving the way for more precise and personalized management of pediatric IBD.
- 26 August 2025
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 31 (11) , 3033-3043
Open AccessTissue MicroRNA Expression Signatures as Diagnostic Biomarkers and Predictors of Residual Disease Activity and Relapse in Treatment-Naïve Pediatric Inflammatory Bowel Disease
Background: Identifying novel diagnostic and prognostic biomarkers for pediatric inflammatory bowel diseases (PIBD), including Crohn’s disease (pCD) and ulcerative colitis (pUC), is essential for enhancing treatment outcomes. MicroRNAs (miRNAs) have been recognized for their broader relevance in PIBD pathogenesis. This study investigates their diagnostic potential and clinical utility in PIBD. Methods: This prospective, monocentric study, with retrospective validation, involved 119 PIBD patients (58 pCD, 61 pUC) and 39 non-IBD controls. Small RNA next-generation sequencing was performed on fresh-frozen gut biopsies, targeting histopathologically confirmed inflamed areas. Twenty-five dysregulated miRNA candidates were validated via RT-qPCR in formalin-fixed, paraffin-embedded gut biopsies. Logistic regression was used to establish diagnostic and prognostic miRNA expression signatures. Results: A diagnostic signature of 5 miRNAs (miR-223-3p, miR-34a-5p, miR-194-5p, miR-215-5p, miR-338-3p) distinguished pCD from non-IBD with 96.49% accuracy. Two miRNAs (miR-223-3p, miR-194-5p) differentiated pUC from non-IBD with 100% accuracy, and miR-215-5p distinguished pCD from pUC specimens with 83.54% accuracy. For treatment-naïve pCD patients, 7 miRNAs predicted residual disease activity at 3 months with 100% accuracy. Additionally, a distinct signature predicted the risk of relapse within 12 months with an accuracy of 84.21%. Conclusions: In this study, we have established tissue miRNA expression signatures with significant diagnostic and prognostic potential for use in PIBD. These findings aid in stratifying disease severity and risk, paving the way for more precise and personalized management of pediatric IBD.
- Open Access
- 1 May 2025
- Published by Springer Nature in BMC Pediatrics
- Vol. 25 (1) , 1-6
Aseptic abscess syndrome as first manifestation of Crohn’s disease – a case report
There exist multiple extraintestinal manifestations of inflammatory bowel disease. The most common are arthritis, aphthous stomatitis, or uveitis. Aseptic abscess syndrome is not usually included among these extraintestinal manifestations. In our case report, we present a rare case of aseptic abscess syndrome as the first manifestation of inflammatory bowel disease. We present the case of a 10-year-old girl whose only initial medical issue was recurrent submandibular lymphadenitis unresponsive to standard antibiotic therapy. A broad differential diagnosis was initiated to exclude an infectious etiology. Eventually, it was necessary to proceed with extirpation of the suspected lymph node. Histological examination showed suppurative granulomatous inflammation, so it was further examined for noninfectious cause. Blood tests revealed positivity of ASCA antibodies (Anti-Saccharomyces cerevisiae) in both IgA and IgG classes. Despite absence of typical gastrointestinal symptoms, bowel ultrasound was performed, followed by magnetic resonance enterography. Both showed inflammatory changes in the terminal ileum. Subsequent endoscopy of the gastrointestinal tract and histological examination of biopsy specimens confirmed a diagnosis of Crohn’s disease with terminal ileum and rectum involvement. A standard treatment based on current guidelines led to remission without recurrence of lymphadenitis. In cases of lymphadenitis that does not respond to standard antibiotic treatment, diagnosis of aseptic abscess syndrome should be considered as a potential etiology and, subsequently, inflammatory bowel disease should be investigated, given that this syndrome is associated with inflammatory bowel disease in as many as 70% of cases. To our knowledge, this is the first published case report describing aseptic abscess syndrome affecting cervical lymph nodes as an extraintestinal manifestation of pediatric Crohn’s disease.
- 1 May 2025
- Published by Springer Nature in BMC Pediatrics
- Vol. 25 (1) , 1-6
Open AccessAseptic abscess syndrome as first manifestation of Crohn’s disease – a case report
There exist multiple extraintestinal manifestations of inflammatory bowel disease. The most common are arthritis, aphthous stomatitis, or uveitis. Aseptic abscess syndrome is not usually included among these extraintestinal manifestations. In our case report, we present a rare case of aseptic abscess syndrome as the first manifestation of inflammatory bowel disease. We present the case of a 10-year-old girl whose only initial medical issue was recurrent submandibular lymphadenitis unresponsive to standard antibiotic therapy. A broad differential diagnosis was initiated to exclude an infectious etiology. Eventually, it was necessary to proceed with extirpation of the suspected lymph node. Histological examination showed suppurative granulomatous inflammation, so it was further examined for noninfectious cause. Blood tests revealed positivity of ASCA antibodies (Anti-Saccharomyces cerevisiae) in both IgA and IgG classes. Despite absence of typical gastrointestinal symptoms, bowel ultrasound was performed, followed by magnetic resonance enterography. Both showed inflammatory changes in the terminal ileum. Subsequent endoscopy of the gastrointestinal tract and histological examination of biopsy specimens confirmed a diagnosis of Crohn’s disease with terminal ileum and rectum involvement. A standard treatment based on current guidelines led to remission without recurrence of lymphadenitis. In cases of lymphadenitis that does not respond to standard antibiotic treatment, diagnosis of aseptic abscess syndrome should be considered as a potential etiology and, subsequently, inflammatory bowel disease should be investigated, given that this syndrome is associated with inflammatory bowel disease in as many as 70% of cases. To our knowledge, this is the first published case report describing aseptic abscess syndrome affecting cervical lymph nodes as an extraintestinal manifestation of pediatric Crohn’s disease.
- Open Access
- 1 January 2025
- Published by Wiley in Pediatrics International
- Vol. 67 (1) , e70039
Higher toxicity of ingested metallic lead in a toddler compared to an adolescent
- 1 January 2025
- Published by Wiley in Pediatrics International
- Vol. 67 (1) , e70039
Open AccessHigher toxicity of ingested metallic lead in a toddler compared to an adolescent
- Open Access
- 3 December 2024
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 18, 1491770
Wide-spread brain alterations early after the onset of Crohn’s disease in children in remission—a pilot study
Background: The research on possible cerebral involvement in Crohn’s disease (CD) has been largely marginalized and failed to capitalize on recent developments in magnetic resonance imaging (MRI).Objective: This cross-sectional pilot study searches for eventual macrostructural and microstructural brain affection in CD in remission and early after the disease onset.Methods: 14 paediatric CD patients and 14 healthy controls underwent structural, diffusion weighted imaging and quantitative relaxation metrics acquisition, both conventional free precession and adiabatic rotating frame transverse and longitudinal relaxation time constants as markers of myelination, iron content and cellular loss.Results: While no inter-group differences in cortical thickness and relaxation metrics were found, lower mean diffusivity and higher intracellular volume fraction were detected in CD patients over vast cortical regions essential for the regulation of the autonomous nervous system, sensorimotor processing, cognition and behavior, pointing to wide-spread cytotoxic oedema in the absence of demyelination, iron deposition or atrophy.Conclusion: Although still requiring further validation in longitudinal projects enrolling larger numbers of subjects, this study provides an indication of wide-spread cortical oedema in CD patients very early after the disease onset and sets possible directions for further research.
- 3 December 2024
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 18, 1491770
Open AccessWide-spread brain alterations early after the onset of Crohn’s disease in children in remission—a pilot study
Background: The research on possible cerebral involvement in Crohn’s disease (CD) has been largely marginalized and failed to capitalize on recent developments in magnetic resonance imaging (MRI).Objective: This cross-sectional pilot study searches for eventual macrostructural and microstructural brain affection in CD in remission and early after the disease onset.Methods: 14 paediatric CD patients and 14 healthy controls underwent structural, diffusion weighted imaging and quantitative relaxation metrics acquisition, both conventional free precession and adiabatic rotating frame transverse and longitudinal relaxation time constants as markers of myelination, iron content and cellular loss.Results: While no inter-group differences in cortical thickness and relaxation metrics were found, lower mean diffusivity and higher intracellular volume fraction were detected in CD patients over vast cortical regions essential for the regulation of the autonomous nervous system, sensorimotor processing, cognition and behavior, pointing to wide-spread cytotoxic oedema in the absence of demyelination, iron deposition or atrophy.Conclusion: Although still requiring further validation in longitudinal projects enrolling larger numbers of subjects, this study provides an indication of wide-spread cortical oedema in CD patients very early after the disease onset and sets possible directions for further research.
- Open Access
- 1 August 2024
- Published by Galen, spol. s r.o. in Ceskoslovenska Pediatrie
- Vol. 79 (4) , 226-232
Malabsorption syndromes
Malabsorp?n? syndromy p?edstavuj? rozs?hlou skupinu onemocn?n?, pro kter? je typick? porucha intralumin?ln?ho tr?ven? ?i vst?eb?v?n? ?ivin. Klinicky se manifestuj? jako pr?jem, steatorea, nad?m?n? anebo neprosp?v?n?. N?kter? jednotky mohou b?t... Malabsorp?n? syndromy p?edstavuj? rozs?hlou skupinu onemocn?n?, pro kter? je typick? porucha intralumin?ln?ho tr?ven? ?i vst?eb?v?n? ?ivin. Klinicky se manifestuj? jako pr?jem, steatorea, nad?m?n? anebo neprosp?v?n?. N?kter? jednotky mohou b?t...
- 1 August 2024
- Published by Galen, spol. s r.o. in Ceskoslovenska Pediatrie
- Vol. 79 (4) , 226-232
Open AccessMalabsorption syndromes
Malabsorp?n? syndromy p?edstavuj? rozs?hlou skupinu onemocn?n?, pro kter? je typick? porucha intralumin?ln?ho tr?ven? ?i vst?eb?v?n? ?ivin. Klinicky se manifestuj? jako pr?jem, steatorea, nad?m?n? anebo neprosp?v?n?. N?kter? jednotky mohou b?t... Malabsorp?n? syndromy p?edstavuj? rozs?hlou skupinu onemocn?n?, pro kter? je typick? porucha intralumin?ln?ho tr?ven? ?i vst?eb?v?n? ?ivin. Klinicky se manifestuj? jako pr?jem, steatorea, nad?m?n? anebo neprosp?v?n?. N?kter? jednotky mohou b?t...
- Open Access
- 2 May 2024
- Published by Springer Nature in Maternal Health, Neonatology and Perinatology
- Vol. 10 (1) , 1-6
Hydrocolpos causing bowel obstruction in a preterm newborn: a case report
Background: Imperforate hymen is the most common congenital defect of the female urogenital tract. The spectrum of clinical manifestations is broad, ranging from mild cases undiagnosed until adolescence to severe cases of giant intraabdominal masses. The most common complication of hydrocolpos is bladder compression, resulting in obstructive uropathy and hydronephrosis. Case presentation: We present here the case of a preterm neonate who was admitted to the surgical neonatal intensive care unit for bowel obstruction. The baby did not appear septic or unwell, a small amount of meconium passed frequently, and no bilious gastric residuals occurred. Based on these findings, acute abdominal obstruction was doubtful, and the surgeon chose a conservative (watch and wait) approach. Subsequently, we performed abdominal ultrasound and magnetic resonance imaging based on unclear information about a suspicious abdominal mass raised by the gynecologist shortly before the emergency C-section. The final diagnosis was congenital hydrocolpos due to imperforate hymen. The pediatric gynecologist indicated an incision of the imperforate hymen under general anesthesia. The incision resolved abdominal distention as well as the bowel obstruction. Conclusion: The presentation of hydrocolpos was not typical (no bulging in the vaginal introitus) in our case, and clinical symptoms implied acute bowel obstruction shortly after birth. The surgeon chose a conservative (watch and wait) approach as the baby did not appear unwell on the second day of life. Fortunately, diagnostic laparotomy was not required as the next step in bowel obstruction management. All clinical symptoms resolved after a minor surgical procedure.
- 2 May 2024
- Published by Springer Nature in Maternal Health, Neonatology and Perinatology
- Vol. 10 (1) , 1-6
Open AccessHydrocolpos causing bowel obstruction in a preterm newborn: a case report
Background: Imperforate hymen is the most common congenital defect of the female urogenital tract. The spectrum of clinical manifestations is broad, ranging from mild cases undiagnosed until adolescence to severe cases of giant intraabdominal masses. The most common complication of hydrocolpos is bladder compression, resulting in obstructive uropathy and hydronephrosis. Case presentation: We present here the case of a preterm neonate who was admitted to the surgical neonatal intensive care unit for bowel obstruction. The baby did not appear septic or unwell, a small amount of meconium passed frequently, and no bilious gastric residuals occurred. Based on these findings, acute abdominal obstruction was doubtful, and the surgeon chose a conservative (watch and wait) approach. Subsequently, we performed abdominal ultrasound and magnetic resonance imaging based on unclear information about a suspicious abdominal mass raised by the gynecologist shortly before the emergency C-section. The final diagnosis was congenital hydrocolpos due to imperforate hymen. The pediatric gynecologist indicated an incision of the imperforate hymen under general anesthesia. The incision resolved abdominal distention as well as the bowel obstruction. Conclusion: The presentation of hydrocolpos was not typical (no bulging in the vaginal introitus) in our case, and clinical symptoms implied acute bowel obstruction shortly after birth. The surgeon chose a conservative (watch and wait) approach as the baby did not appear unwell on the second day of life. Fortunately, diagnostic laparotomy was not required as the next step in bowel obstruction management. All clinical symptoms resolved after a minor surgical procedure.